The aim with this study is to provide immunotherapy with vitamin D and phenylbutyrate to
treatment-naive HIV infected patients to induce important antimicrobial defence mechanisms
and decreased inflammation.
Phase:
Phase 2
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Addis Ababa University Armauer Hansen Research Institute, Ethiopia
Treatments:
4-phenylbutyric acid Anti-Infective Agents Cholecalciferol Ergocalciferols Vitamin D Vitamins